Description
Indication & Scope
Keverprazan Hydrochloride Tablets (Beiwen) are indicated for the treatment of duodenal ulcer and reflux esophagitis.
- Mechanism
As a potassium-competitive acid blocker, it selectively inhibits gastric H+/K+-ATPase to suppress gastric acid secretion, rapidly relieve acid-related symptoms and promote mucosal healing. - Drug class
Chemical synthetic anti-ulcer agent, potassium-competitive acid blocker (P-CAB). - Clinical use
Phase III clinical trials confirmed its good efficacy and safety in acid-related diseases; administered orally once daily with flexible dosing course according to disease conditions.
| Generic Name | Keverprazan Hydrochloride Tablets |
| Brand Name | BeiWen® |
| Ingredient | Keverprazan Hydrochloride |
| Dosage Form | Film-coated tablets |
| Package | 10mg×8 tablets/blister/sachet/box |
| Conditions Treated | Treatment of duodenal ulcer and reflux esophagitis |
| Taboos | Contraindicated for patients with hypersensitivity to the active ingredient or any excipients of this product, or those with severe allergic history |
| Place of origin | Jiangsu, China |
| Priscription Type | Prescription drug (Rx) |
| Storage Conditions | Seal tightly, store below 30℃, keep away from moisture and light |
| Manufacturer | Jiangsu Carephar Pharmaceutical Co., Ltd. |
| Registration Authority | National Medical Products Administration (NMPA) |
| Approval number | H20230003 |
| Date of Revision | February 10, 2023 |
| Shelf Life | 24 months |
How to use ?
Recommended Dose: 10 mg once daily by oral administration. Duodenal ulcer patients take the drug for 4 weeks, and reflux esophagitis patients take it for 8 weeks.
Time: Take on an empty stomach once daily at a fixed time; no adjustment of administration time is needed for meals.
Interaction:Avoid combined use with other acid-suppressing agents. Concomitant use with antibiotics is allowed for Helicobacter pylori eradication. No intravenous administration, for oral use only.
Side effects: Mild and transient reactions commonly occur: diarrhea, abdominal distension, nausea, headache and dizziness. Rare adverse reactions include elevated liver enzymes and rash; severe adverse reactions are extremely uncommon.
Important Notice
This product shall only be used for post-exposure rabies prophylaxis by professional medical staff. It must be applied combined with rabies vaccine and injected via wound infiltration plus intramuscular routes as specified. Do not administer intravenously or alter the dosage at will. Hypersensitivity monitoring is required throughout the whole injection process.
Packaging & Shipping
Packaging
Original manufacturer’s packaging with secure export carton. Customized export packaging is available upon request.
Shipping Methods
Express Courier (EMS, DHL, FedEx, UPS), Air Freight, and Sea Freight. Cold-chain transportation is available for products requiring temperature-controlled logistics.
Export Support
Certificate of Analysis
GMP Certificate
Commercial Invoice
Packing List & CPP
Cold Chain Logistics
Customs Documentation
Scientific and regulatory sources
FAQ
What is Keverprazan hydrochloride tablets?
It is known as potassium-competitive acid blockers (P-CABs).
Can it be combined with other acid-suppressing drugs?
Combined use with other acid suppressants is not recommended. It can be combined with antibiotics for H. pylori eradication.
Can patients with duodenal ulcer stop taking medicine after symptom relief?
No, complete the full 4-week treatment course to avoid recurrence.
What is the main cause of reflux esophagitis relieved by this drug?
Suppressing gastric acid reduces acid stimulation to esophageal mucosa and promotes mucosal healing.
BeiWen®Keverprazan Hydrochloride Tablets | DU And RE | DengYueRX
INN: Keverprazan Hydrochloride
Indications: DU (duodenal ulcer) And RE (reflux esophagitis)
Dosage Form: Film-coated tablets
Strength: 10mg/tablet
Low MOQ
WHO-GMP
Worldwide Delivery
Compliance and Regulatory Documents
Related Products
